Insmed Incorporated - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
INSM Nasdaq 2830 www.insmed.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Insmed Incorporated

What Insmed Stock's Premium Is Actually Buying - Aug 7th, 2026 9:39 am
Has Insmed (INSM) Risen Above Fair Value After Its 3 Year Run? - Aug 7th, 2026 9:15 am
Insmed Tops Q2 Earnings Estimates, Stock Soars 34% on Brinsupri Uptake - Aug 7th, 2026 8:36 am
US Stock Market Today S&P 500 Futures Edge Higher On Mixed Growth Signals - Aug 7th, 2026 2:14 am
Insmed (INSM) Is Up 30.6% After Steeply Narrowing Losses And Raising 2026 Revenue Guidance – What’s Changed - Aug 6th, 2026 11:13 pm
Insmed (INSM) Soars 33.86% as Brinsupri Drives Fourfold Growth. Here’s What to Watch Next - Aug 6th, 2026 7:49 pm
Insmed Catapults 34%, Leading A Biotech Rally. But Mirum Takes A Bath. - Aug 6th, 2026 2:12 pm
Insmed Inc (INSM) (Q2 2026) Earnings Call Highlights: BRINSUPRI Surges 49% Sequentially, ... - Aug 6th, 2026 1:05 pm
Insmed Q2 Earnings Call Highlights - Aug 6th, 2026 1:04 pm
Insmed Raises BRINSUPRI Revenue Guidance After Strong Q2 Growth and Expands Peak Sales Outlook - Aug 6th, 2026 8:56 am
Insmed (INSM) Reports Q2 Earnings: What Key Metrics Have to Say - Aug 6th, 2026 7:30 am
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Thursday Amid Corporate Earnings Deluge - Aug 6th, 2026 7:21 am
Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates - Aug 6th, 2026 6:20 am
Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update - Aug 6th, 2026 5:00 am
Arcutis Biotherapeutics, Inc. (ARQT) Q2 Earnings and Revenues Surpass Estimates - Aug 5th, 2026 3:10 pm
Here’s Why Baron Health Care Fund Remains Bullish on Insmed (INSM) - Aug 4th, 2026 8:12 am
Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates - Jul 30th, 2026 4:00 pm
Insmed Incorporated’s (INSM) Commercial Acceleration Overshadows Q1 Stumble - Jul 30th, 2026 8:23 am
Insmed (INSM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Jul 30th, 2026 8:00 am
EMV Capital: ProAxsis eyes COPD market breakthrough with Imperial College London study - Jul 29th, 2026 4:03 am